ALNOV:EPA
Novacyt SA
€ 0.46
arrow_upward
+1.20%(+0.0055) Siku 1
23 Okt, 17:35:29 GMT +2 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALNOV...
Fungua
€ 0.46
Juu
€ 0.48
Chini
€ 0.46
Mtaji wa soko
32.46M
Wastani wa kiasi cha mauzo
elfu 192.39
Kiasi cha mauzo ya hisa
elfu 160.58
Juu kwa wiki 52
€ 1.04
Chini kwa wiki 52
€ 0.29
EPS
-€ 0.37
Hisa za wawekezaji
72.59M
Idadi ya wafanyakazi
228
Fungua
€ 0.46
Juu
€ 0.48
Chini
€ 0.46
Mtaji wa soko
32.46M
Wastani wa kiasi cha mauzo
elfu 192.39
Kiasi cha mauzo ya hisa
elfu 160.58
Juu kwa wiki 52
€ 1.04
Chini kwa wiki 52
€ 0.29
EPS
-€ 0.37
Hisa za wawekezaji
72.59M
Idadi ya wafanyakazi
228
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Foreign Policy Journal
·
dakika 37 zilizopita
Qualcomm (NASDAQ: QCOM) Plans Global "Performance-Focused" Layoffs Beginning In November As Smartphone Revenue Slides
CryptoSlate
·
saa 1 iliyopita
NYSE’s owner is backing 24/7 stock tokens without Wall Street’s usual price rules
Foreign Policy Journal
·
saa 1 iliyopita
Canadian Publishers Push Back Against Meta Platforms (NASDAQ: META) Over AI Content Scraping Terms
WSJ
·
saa 21 zilizopita
Stocks Pulled in Two Directions, Fall to End Volatile Week
Wasifu
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Kuhusu Novacyt SA
Afisa Mkuu Mtendaji (CEO)David Allmond
Wafanyakazi228
Lilianzishwa3 Jul 2006
Makao makuu-
Sekta-
Tovutinovacyt.com